Moderna Reinstated With an Underperform at BofA

Yahoo Finance20:05

BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41

Futu News16:31 · Ratings

BofA Downgrades Moderna, Says It's 'Tough Time' to Be Vaccine Maker

Yahoo Finance06:37

BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking Alpha06:01

FDA Highlights Safety Challenges And Development Needs For Pediatric RSV Vaccines Amid Historical Concerns And Recent MRNA Trial Pauses; Focus On Addressing Unmet Needs For Infants And Toddlers.

Benzinga02:50

Unpacking the Latest Options Trading Trends in Moderna

BenzingaDec 10 23:45